Effects of Multidisciplinary Rehabilitation Enhanced with Neuropsychological Treatment on Post-Acute SARS-CoV-2 Cognitive Impairment (Brain Fog): An Observational Study.

SARS-CoV-2 brain fog cognitive impairment long COVID neuropsychology rehabilitation

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
12 May 2023
Historique:
received: 08 04 2023
revised: 10 05 2023
accepted: 11 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Concentration and memory impairment (named "brain fog") represents a frequent and disabling neuropsychological sequela in post-acute COVID-19 syndrome (PACS) patients. The aim of this study was to assess whether neurocognitive function could improve after a multidisciplinary rehabilitation program enhanced with individualized neuropsychological treatment. A prospective monocentric registry of PACS patients consecutively admitted to our Rehabilitation Unit was created. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive impairment at admission and discharge. A total of sixty-four (64) PACS patients, fifty-six (56) of them with brain fog, were treated with a day-by-day individualized psychological intervention of cognitive stimulation (45 min) on top of a standard in-hospital rehabilitation program. The mean duration of the acute-phase hospitalization was 55.8 ± 25.8 days and the mean in-hospital rehabilitation duration was 30 ± 10 days. The mean age of the patients was 67.3 ± 10.4 years, 66% of them were male, none had a previous diagnosis of dementia, and 66% of the entire sample had experienced severe COVID-19. At admission, only 12% of the patients had normal cognitive function, while 57% showed mild, 28% moderate, and 3% severe cognitive impairment. After psychological treatment, a significant improvement in the MoCA score was found (20.4 ± 5 vs. 24.7 ± 3.7;

Identifiants

pubmed: 37239263
pii: brainsci13050791
doi: 10.3390/brainsci13050791
pmc: PMC10216015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ann Intern Med. 2021 May;174(5):717-719
pubmed: 33284682
PLoS One. 2021 Feb 8;16(2):e0246590
pubmed: 33556127
Cell. 2022 Jul 7;185(14):2452-2468.e16
pubmed: 35768006
Neurology. 2013 Mar 12;80(11):1048-56
pubmed: 23390179
Int Psychogeriatr. 2012 Nov;24(11):1749-55
pubmed: 22687278
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
J Neurol. 2022 Jan;269(1):44-46
pubmed: 34143277
Clin Rev Allergy Immunol. 2023 Feb;64(1):66-74
pubmed: 33609255
Int J Environ Res Public Health. 2022 Jul 29;19(15):
pubmed: 35954630
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
G Ital Cardiol (Rome). 2020 Jun;21(6):417-420
pubmed: 32425184
J Intern Med. 2023 Feb;293(2):246-258
pubmed: 36478477
Am J Med Sci. 2023 May;365(5):472-474
pubmed: 36632867
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
J Med Virol. 2021 Feb;93(2):1175-1179
pubmed: 32841387
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Med Virol. 2022 Mar;94(3):979-984
pubmed: 34672377
Ann Neurol. 2008 Apr;63(4):494-506
pubmed: 18300306
Healthcare (Basel). 2022 Sep 24;10(10):
pubmed: 36292305
Alzheimers Dement. 2017 Aug;13(8):903-912
pubmed: 28216393
Sensors (Basel). 2022 Sep 01;22(17):
pubmed: 36081063
BMJ Open. 2022 Feb 11;12(2):e056366
pubmed: 35149572
Presse Med. 2022 Jun;51(2):104090
pubmed: 34718113
Disabil Rehabil. 2022 Nov;44(22):6833-6840
pubmed: 34559592
Cell. 2019 Jan 10;176(1-2):43-55.e13
pubmed: 30528430

Auteurs

Paolo Rabaiotti (P)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Chiara Ciracì (C)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Davide Donelli (D)

Division of Cardiology, University Hospital of Parma, University of Parma, Viale Antonio Gramsci, 14, 43126 Parma, Italy.

Carlotta Oggioni (C)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Beatrice Rizzi (B)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Federica Savi (F)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Michele Antonelli (M)

Department of Public Health, AUSL-IRCCS of Reggio Emilia, Via Amendola, 42122 Reggio Emilia, Italy.

Matteo Rizzato (M)

"Humandive", Piazzale XX Settembre, 1/B, 33170 Pordenone, Italy.

Luca Moderato (L)

Cardiology Department, "Guglielmo da Saliceto" Hospital, Via Taverna Giuseppe, 49, 29121 Piacenza, Italy.

Valerio Brambilla (V)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Valentina Ziveri (V)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Lorenzo Brambilla (L)

IRCCS Fondazione Don Carlo Gnocchi, Via Carlo Girola, 30, 20162 Milano, Italy.

Matteo Bini (M)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Antonio Nouvenne (A)

U.O. Medicina Interna di Continuità, Azienda Ospedaliero-Università di Parma, Via Gramsci, 14, 43126 Parma, Italy.

Davide Lazzeroni (D)

Prevention and Rehabilitation Unit, Parma, IRCCS Fondazione Don Gnocchi, Piazzale Servi, 3, 43100 Parma, Italy.

Classifications MeSH